U.S. orders 2.5 mln more doses of Bavarian Nordic’s vaccine for monkeypox
Written by Black Hot Fire Network on July 1, 2022
An employee works on a vaccine based on the monkeypox vaccine that has already been developed by the vaccine company Bavarian Nordic at a laboratory of the company in Martinsried near Munich, Germany, May 24, 2022. The company, headquartered in Denmark, is the only one in the world to have approval for a smallpox vaccine called Jynneos in the U.S. and Imvanex in Europe, which is also effective against monkeypox. REUTERS/Lukas Barth
Register now for . . .
